Emerald Health Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/16/2024
Emerald Health Therapeutics Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Emerald Health Therapeutics, with an average price target of C$0.00. This potential loss of -,100 percent from the previous closing price in October, 2022 is calculated on a high forecast of C$0.00 and a low estimate of C$0.00. Even if you're not interested in EMH stock, you may be interested in its competitors.
N/A
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TLRY Stock Forecast | Tilray, Inc. prior to merger w... | - |
6
|
$18.34 | Buy/Sell | $22.00 | -100.00% |
| TLRY Stock Forecast | Tilray Brands | Outperform |
6
|
$1.78 | Buy/Sell | $2.74 | 23.60% |
| SNDL Stock Forecast | SNDL | Buy |
7
|
$1.92 | Buy/Sell | $4.96 | 156.25% |
| WEED Stock Forecast | Canopy Growth | Hold |
7
|
C$9.59 | Buy/Sell | C$0.94 | -37.43% |
| ACB Stock Forecast | Aurora Cannabis | Outperform |
6
|
C$8.63 | Buy/Sell | C$1.06 | -7.30% |
Emerald Health Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last year, Emerald Health Therapeutics's Revenue has decreased by 17.55%, going from C$11.74M to C$9.68M. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach C$11.74M – an increase of 21.28%. Over the next nine years, experts anticipate that Revenue growth for Emerald Health Therapeutics will be 15.58%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LOVE Stock Forecast | Cannara Biotech | - |
-12
|
C$0.93 | Buy/Sell | C$0.00 | -100.00% |
| DB Stock Forecast | Decibel Cannabis | Buy |
0
|
C$0.14 | Buy/Sell | C$0.50 | 185.71% |
| HUGE Stock Forecast | FSD Pharma | - |
4
|
C$0.70 | Buy/Sell | C$15.45 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ENTG Stock Forecast | Entourage Health | - |
0
|
C$0.01 | Buy/Sell | C$0.05 | -100.00% |
| DN Stock Forecast | Delta 9 Cannabis | Hold |
0
|
C$0.04 | Buy/Sell | C$0.06 | 50.00% |
| GAIA Stock Forecast | Gaia Grow | - |
0
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
Emerald Health Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Emerald Health Therapeutics's EBITDA has decreased from C$-23.34M to C$-18.45M – a 20.95% drop! For next year, the 0 analysts predict EBITDA of C$-23.34M, which would mean an increase of 26.50%. Over the next nine years, the pros' prediction is EBITDAof C$-22.11M, which would mean a nine-year growth forecast of 19.86%.
Emerald Health Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last year, Emerald Health Therapeutics has seen a decline in its EBIT, from C$-27.00M to C$-20.73M – a 23.22% decrease. In the next year, analysts expect EBIT to reach C$-27.00M – an increase of 30.25%. For the next nine years, the forecast is for EBIT to grow by 23.03%.
Site Navigation
.jpg)